Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study To Investigate The Safety And Possible Clinical Benefit Of Multistem(r) In Patients With Moderate To Severe Ulcerative Colitis

ClinicalTrials.gov ID: NCT01240915

Public ClinicalTrials.gov record NCT01240915. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 5:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study To Investigate The Safety And Efficacy Of Multistem (Pf-05285401) In Subjects With Moderate To Severe Ulcerative Colitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

MultiStem(r) is a new biological product, manufactured from human stem cells obtained from adult bone marrow or other nonembryonic tissue sources. Factors expressed by MultiStem cells are believed to reduce inflammation and regulate immune system function, protect damaged or injured cells and tissue, promote formation of new blood vessels, and augment tissue repair and healing. MultiStem cell treatment resulted in significant efficacy in a mouse model of Graft versus Host Disease with almost complete reversal of gastrointestinal pathology (similar to pathology that would be expected in Ulcerative Colitis). These data, together with safety data generated in 2 other clinical trials, suggest that MultiStem has the potential to be a new treatment option for patients with ulcerative colitis. This is the first study of MultiStem in this patient population and will cautiously explore the safety/toleration and potential benefit of this new treatment in patients with moderate to severe disease.

Study identification

NCT ID
NCT01240915
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
105 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2011
Primary completion
Oct 31, 2014
Completion
Oct 31, 2014
Last update posted
Feb 22, 2016

2011 – 2014

United States locations

U.S. sites
37
U.S. states
15
U.S. cities
27
Facility City State ZIP Site status
University of California San Francisco San Francisco California 94115
USCF Endoscopy Unit at Mount Zion San Francisco California 94115
Clinical Research of the Rockies Lafayette Colorado 80026
Rocky Mountain Gastroenterology Associates, LLC Lakewood Colorado 80215
Arapahoe Gastroenterology, PC Littleton Colorado 80120
Metropolitan Gastroenterology Group, PC Washington D.C. District of Columbia 20006
Gastroenterology Consultants of Clearwater Clearwater Florida 33756
West Coast Endoscopy Center Clearwater Florida 33756
Clinical Research of West Florida, Inc. Clearwater Florida 33765
Borland-Groover Clinic Jacksonville Florida 32256
Jacksonville Center for Endoscopy Jacksonville Florida 32256
Miami Research Associates South Miami Florida 33143
University of Chicago Medical Center Chicago Illinois 60637
Cotton-O'Neil Clinical Research Center, Digestive Health Topeka Kansas 66606
University of Louisville Healthcare Outpatient Center Louisville Kentucky 40202
University of Louisville Hospital Louisville Kentucky 40202
Metropolitan Gastroenterology Group, PC - Chevy Chase Clinical Research Chevy Chase Maryland 20815
Endoscopic Microsurgery Associates, PA Towson Maryland 21204
Clinical Research Institute of Michigan, LLC Chesterfield Michigan 48047
Center for Digestive Health Troy Michigan 48098
Utica Surgery Center Utica Michigan 48317
Surgery Center of Columbia Columbia Missouri 65201
Center for Digestive and Liver Diseases, Inc. Mexico Missouri 65265
Present, Chapman, Steinlauf and Marion New York New York 10028
Mount Sinai School of Medicine New York New York 10029
Asher Kornbluth, MD PC New York New York 10128
Charlotte Gastroenterology and Hepatology, PLLC Charlotte North Carolina 28207
Wake Internal Medicine Consultants, Inc. Raleigh North Carolina 27612
Wake Research Associates Raleigh North Carolina 27612
Wake Forest University University Baptist Medical Center - Internal Medicine Winston-Salem North Carolina 27157
Gastro One Germantown Tennessee 38138
Vanderbilt University Medical Center Nashville Tennessee 37232-1375
Digestive and Liver Disease Specialists Norfolk Virginia 23502
Sentara Leigh Hospital Norfolk Virginia 23502
Sentara Norfolk General Hospital Norfolk Virginia 23507
McGuire DVAMC Richmond Virginia 23249
University of Washington Medical Center Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01240915, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2016 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01240915 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →